AndrewBerchuckMD
Obstetrics & Gynecology • Durham, NCGeneral Gynecology, Gynecologic Oncology
Professor of Obstetrics & Gynecology, Duke University
Dr. Berchuck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Cir
Durham, NC 27710Phone+1 919-684-8111
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 1985 - 1987
The MetroHealth System/Case Western Reserve UniversityResidency, Obstetrics and Gynecology, 1982 - 1984
Case Western Reserve University School of MedicineClass of 1980
Certifications & Licensure
NC State Medical License 1987 - 2025
OH State Medical License 1983 - 1988- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Tissue Bank of Biological Specimens From Patients With Gynecologic Disease Start of enrollment: 2006 Mar 01
- BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 1 citationsFrailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicity.Clare Meernik, Oyomoare L Osazuwa-Peters, Lauren E Wilson, Ashwini Joshi, Maria Pisu
Gynecologic Oncology. 2024-11-01 - Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer.Pamela N Peters, Regina S Whitaker, Felicia Lim, Shonagh Russell, Elizabeth A Bloom
Neoplasia. 2024-11-01 - 1 citationsMetformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada.Paramdeep Kaur, Andrew Berchuck, Anne Chase, Bronwyn Grout, Cindy McKinnon Deurloo
Neoplasia. 2024-10-01
Journal Articles
- Association of p16 Expression with Prognosis Varies Across Ovarian Carcinoma Histotypes: An Ovarian Tumor Tissue Analysis Consortium StudyRobert P Edwards, Beth Y Karlan, Andrew Berchuck, The Journal of Pathology: Clinical Research
- Variants in Genes Encoding Small GTPases and Association with Epithelial Ovarian Cancer SusceptibilityJulie M Cunningham, Robert P Edwards, Elizabeth M Poole, Tanja Pejovic, Karen Lu, Kunle Odunsi, Beth Y Karlan, Christine S Walsh, Douglas A Levine, Andrew Berchuck, Da..., PLoS One
- Functional Mechanisms Underlying Pleiotropic Risk Alleles at the 19p13.1 Breast–Ovarian Cancer Susceptibility LocusSusan M Domchek, Beth Y Karlan, Katherine L Nathanson, Kenneth Offit, Banu K Arun, Andrew Berchuck, Patricia A Ganz, Douglas A Levine, Nature
Press Mentions
Duke Marks 50 Years of Gynecologic Care; Celebrates Legacies of Oncology Doctors and NursesJanuary 25th, 2023
You’ll Never Guess Which Company Is Reinventing Health BenefitsAugust 31st, 2018
Balancing Evidence, Value for Broadening Use of PARP InhibitorsNovember 29th, 2017- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
